**Core Concept**
The underlying principle in this question is the management of hypertension in diabetic patients with microalbuminuria to prevent progression of renal failure. Microalbuminuria is an early sign of diabetic nephropathy, and controlling hypertension is crucial to delay the progression of renal disease.

**Why the Correct Answer is Right**
In diabetic patients with microalbuminuria, the goal of antihypertensive therapy is to reduce proteinuria and slow the progression of renal disease. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) are the preferred initial treatments for hypertension in diabetic patients with microalbuminuria. These agents reduce intraglomerular pressure, decrease proteinuria, and slow the progression of renal disease. They also have a protective effect on the kidneys by reducing the levels of aldosterone, which can contribute to fibrosis and further renal damage.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because beta-blockers are not the preferred initial treatment for hypertension in diabetic patients with microalbuminuria. While they can be used in combination with other agents, they do not have the same protective effects on the kidneys as ACE inhibitors or ARBs.

**Option B:** This option is incorrect because calcium channel blockers are not the preferred initial treatment for hypertension in diabetic patients with microalbuminuria. While they can be used in combination with other agents, they do not have the same protective effects on the kidneys as ACE inhibitors or ARBs.

**Option D:** This option is incorrect because diuretics are not the preferred initial treatment for hypertension in diabetic patients with microalbuminuria. While they can be used in combination with other agents, they do not have the same protective effects on the kidneys as ACE inhibitors or ARBs.

**Clinical Pearl / High-Yield Fact**
In diabetic patients with microalbuminuria, the use of ACE inhibitors or ARBs not only slows the progression of renal disease but also has a protective effect on the cardiovascular system by reducing the risk of myocardial infarction and stroke.

**Correct Answer:** C.